June Lee


June Lee is an adjunct professor, pharmaceutical executive, and medical doctor with expertise in cardiology and translational medicine.

Background

June Lee was encouraged to enter academic medicine at an early age, in order to treat her family's hereditary asthma. She received her undergraduate degree in chemistry at Johns Hopkins University in 1988, and earned her medical degree at the University of California, Davis in 1992. She performed residencies in internal medicine and pulmonary medicine at UCLA and UCSF.

Career

Hospital work

Lee served as the medical director of the High-Risk Asthma clinic at San Francisco General Hospital. She maintained an independent research program prior to Genentech, funded by the American Lung Association, to investigate IL-13 induced transcription, among other pulmonary treatments.

Genentech

Lee worked at Genentech for seven years, from 2004 to 2011, as a therapeutic area head. During this time, she was one of the translational medicine staff helping to interpret the data from a large respiratory study – TENOR – that resulted in multiple insights into risk factors and demographics for asthma sufferers.

UCSF

Lee holds a professorship at UCSF in the School of Medicine. She was the director of Early Translational Research at UCSF. From 2011 to 2017, Lee served as the director of the Catalyst Program inside UCSF, which served as an internal incubator for entrepreneurial ideas from faculty, in addition to providing de-risking outsourcing partnerships and educational modules for graduate students.

Myokardia

Lee serves as the chief operating officer for Myokardia, in which capacity she helps to develop precision health treatments against cardiomyopathies.

Public service

Lee has been a volunteer member of the Council of Korean Americans since 2013, and currently sits on its board of directors. She has served previously as chair of the Drug, Device, Discovery, and Development workgroup of UC BRAID.
Lee is a Fellow of the American College of Chest Physicians.